Characterize Fab and Fc Fragments by Cation-Exchange Chromatography

Importance of the topic

The structural and charge heterogeneity of monoclonal antibody (mAb) fragments such as Fab and Fc is critical in the development and quality control of therapeutic antibodies. Cation-exchange chromatography (CEX) coupled with mass spectrometry (MS) provides detailed insight into charge variants, post-translational modifications and fragmentation patterns, which can impact efficacy, stability and immunogenicity of biologics.

Aims and overview of the study

This application note demonstrates the separation of Fab and Fc fragments from papain-digested trastuzumab using a weak cation-exchange column, followed by online desalting and high-resolution Q-TOF MS analysis. Both nonstressed and pH-stressed samples were compared to identify digestion artifacts and stress-induced modifications.

Methodology

Sample preparation involved incubation of trastuzumab with papain at 37 °C, buffer exchange into MES at pH 5.6, and adjustment to 2 mg/mL. A pH-stressed variant was generated by holding the antibody at pH 9.0 for 3 days. Selected CEX fractions were optionally reduced with TCEP for subunit analysis.

Used instrumentation

• CEX system: Agilent 1100/1200 series modules with Agilent Bio MAb NP5 WCX column
• Online desalting: 2.1 × 10 mm cartridge, formic acid/acetonitrile mobile phases
• Mass spectrometer: Agilent 6540 UHD Accurate-Mass Q-TOF with Jet Stream source
• Software: Agilent OpenLAB CDS ChemStation, MassHunter, BioConfirm

Main results and discussion

CEX separation resolved distinct peaks corresponding to intact Fab and Fc fragments and their charge variants. Nonstressed samples showed four peaks: truncated Fab (loss of KTH tripeptide), native Fab, deamidated Fab light chain, and glycosylated Fc. pH-stressed samples exhibited additional deamidation on the heavy chain. Deconvoluted masses confirmed modifications such as asparagine deamidation (+1 Da) and characteristic Fc N-glycan patterns (G0F, G1F, G2F). TCEP reduction aided assignment of light and heavy chain modifications.

Benefits and practical applications of the method

• High resolution CEX-MS enables detailed mapping of charge variants and glycoforms
• Online desalting streamlines sample cleanup and MS compatibility
• Applicable to mAb fragment characterization in biopharmaceutical development and QC

Future trends and opportunities

Advances in column chemistries may further improve resolution of closely related charge variants. Integration with automated fraction collection and data analysis workflows will accelerate throughput. Expansion to other proteolytic enzymes and hybrid fragmentation techniques may deepen structural insights.

Conclusion

The combination of Agilent Bio MAb weak cation-exchange chromatography with online desalting and accurate-mass Q-TOF detection provides a robust platform for the separation and characterization of Fab and Fc fragments and their charge variants. This integrated approach supports detailed quality assessment of therapeutic mAbs.

References

1. I. Vandenheede et al. Characterize mAb Charge Variants by Cation-Exchange Chromatography. Agilent Technologies Application Note 5991-5273EN (2014).